223595-20-8

Basic information

• Product Name: 2,3-Dihydro-(1R)-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole
• Synonyms: 2,3-Dihydro-(1R)-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole;(1R)-2,3-Dihydro-1-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole;(R)-5-(1,3,6,2-Dioxazaborocan-2-yl)-1-methyl-2-tritylisoindoline;2-((1R)-1-Methyl-2-trityl-2,3-dihydro-1H-isoindol-5-yl)-1,3,6,2-dioxazaborocane;(R)-2-(1-methyl-2-tritylisoindolin-5-yl)-1,3,6,2-dioxazaborocane
• CAS NO: 223595-20-8
• Molecular Formula: C₃₂H₃₃BN₂O₂
• Molecular Weight: 488.43
• Mol File: 223595-20-8.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 612.181 °C at 760 mmHg
• Flash Point: 324.035 °C
• Appearance: /
• Density: 1.19
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.646
• CAS DataBase Reference: 2,3-Dihydro-(1R)-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-Dihydro-(1R)-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole(223595-20-8)
• EPA Substance Registry System: 2,3-Dihydro-(1R)-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole(223595-20-8)

Safety Data

• Hazardous Substances Data: 223595-20-8(Hazardous Substances Data)

Usage

General Description

2,3-Dihydro-(1R)-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole is a complex chemical compound that contains a boron-containing heterocycle. 2,3-Dihydro-(1R)-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole is a member of the isoindole family and contains a tetrahydro-1,3,6,2-dioxazaborocin-2-yl substituent. It also contains a triphenylmethyl group. The compound is a chiral molecule, with the (1R)-methyl configuration at the 1-position of the isoindole ring. This chemical may have potential applications in pharmaceuticals, materials science, and organometallic chemistry due to its unique structure and properties. Further research and studies may reveal its specific uses and potential benefits in various industries.

InChI:InChI=1/C32H33BN2O2/c1-25-31-18-17-30(33-36-21-19-34-20-22-37-33)23-26(31)24-35(25)32(27-11-5-2-6-12-27,28-13-7-3-8-14-28)29-15-9-4-10-16-29/h2-18,23,25,34H,19-22,24H2,1H3/t25-/m1/s1

Upstream product

• 111-42-2 2,2'-iminobis[ethanol] 
• 194805-14-6 (+)-(R)-5-bromo-1-methyl-2-(triphenylmethyl)isoindoline 

Downstream Products

• 194804-45-0 ethyl 1-cyclopropyl-8-methoxy-7-[(1R)-1-methyl-2-trityl-2,3-dihydro-1H-5-isoindolyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylate 
• 479091-04-8 1-Cyclopropyl-8-difluoromethoxy-7-((R)-1-methyl-2-trityl-2,3-dihydro-1H-isoindol-5-yl)-1H-quinazolinedione 
• 194804-75-6 garenoxacin 

Relevant articles and documents

Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and composition containing the same as active ingredient

This invention relates to processes for producing a 7-isoindoline-quinolonecarboxylic acid derivative represented by the general formula [1] which is useful as an antibacterial agent, and an intermediate thereof: wherein R1represents a hydrogen atom or a carboxyl-protecting group; R2represents a substituted or unsubstituted alkyl, alkenyl, cycloalkyl, aryl or heterocyclic group; R3represents at least one group selected from hydrogen atom, halogen atoms, substituted or unsubstituted alkyl, alkenyl, cycloalkyl, aryl, alkoxy or alkylthio groups, nitro group, cyano group, acyl groups, protected or unprotected hydroxyl groups and protected or unprotected or substituted or unsubstituted amino groups; R4represents at least one group selected from hydrogen atom, halogen atoms, substituted or unsubstituted alkyl, alkenyl, cycloalkyl, aralkyl, aryl, alkoxy or alkylthio groups, protected or unprotected hydroxyl or imino groups, protected or unprotected or substituted or unsubstituted amino groups, alkylidene groups, oxo group and groups each forming a cycloalkane group together with the carbon atom to which R4bonds; R5represents a hydrogen atom, an amino-protecting group, a substituted or unsubstituted alkyl, cycloalkyl, alkylsulfonyl, arylsulfonyl, acyl or aryl group; R6represents a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl, alkoxy or alkylthio group, a protected or unprotected hydroxyl or amino group or a nitro group; and A represents CH or C—R7in which R7represents a halogen atom, a substituted or unsubstituted alkyl, alkoxy or alkylthio group or a protected or unprotected hydroxyl group, and to a salt of a 7-isoindoline-quinolonecarboxylic acid represented by the general formula [1], a hydrate thereof and a composition comprising them as an active ingredient.